Fundz

Quartzbio, A Part Of Precision For Medicine, Acquires Solvebio And Expands Software-As-A-Service (Saas) Data Management Solutions For Clinical Research & Development (R&D)

PRIVATEJan 24, 2023

Acquiring Company

QuartzBio

Acquired Company

SolveBio

Information TechnologyBiotechnologySoftwareAnalyticsBiotechnologyHealth CareAnalytics

Description

Precision for Medicine, the first global, precision medicine clinical research services organization, today announced the strategic acquisition of SolveBio by QuartzBio.

Quick answer

QuartzBio is acquiring SolveBio, announced January 24, 2023.

How much did QuartzBio pay for SolveBio?
The deal value was not disclosed.
What does QuartzBio do?
QuartzBio helps overcome the data chaos inherent in modern drug development.

Source: Fundz verified event record.

Other recent acquisitions in Analytics and Analytics

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at QuartzBio, and when

When QuartzBio changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day QuartzBio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at QuartzBio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at QuartzBio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

QuartzBio

About

QuartzBio helps overcome the data chaos inherent in modern drug development. We serve clinical operations and translational research teams in oncology, autoimmune, CNS and other biomarker-rich therapeutic areas, whose progress hinges on navigating and connecting a complex data ecosystem. Our suite of fully connected, end-to-end SaaS solutions is engineered specifically to address the challenges of both sample data and biomarker data management – providing a single, scalable data platform solution to the biotech and pharma sectors. For more information, visit Quartzbio.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment QuartzBio makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for QuartzBio's next move

Learn about Strategic plan

Frequently asked

Who acquired SolveBio?

SolveBio was acquired by QuartzBio. The deal was reported on January 24, 2023. QuartzBio helps overcome the data chaos inherent in modern drug development. QuartzBio is privately held and operates in Information Technology.

When did QuartzBio acquire SolveBio?

QuartzBio's acquisition of SolveBio was reported on January 24, 2023. Precision for Medicine, the first global, precision medicine clinical research services organization, today announced the strategic acquisition of SolveBio by QuartzBio. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does SolveBio do?

SolveBio is an industry leader in advanced precision medicine data analytics. Its technology platform enables biopharma customers to lower trial risk, create more effective therapeutics, and compress the time scale of clinical development. It is privately held, operating in Biotechnology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.